Empyema, Pleural
16
3
3
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
31%
5 trials in Phase 3/4
10%
1 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (16)
Trial of Antiseptic Irrigation for Pleural Infection
Evaluation of Efficacy and Safety Parameters of Different Antibiotics Regimens for Management of Empyema
Once Daily Intrapleural Enzyme Therapy in Complicated Parapneumonic Effusion or Empyema
Flush, Lyse, Operate
Chest Drain Regular Flushing in Complicated Parapneumonic Effusions and Empyemas
Comparison of Lung Expansion After Uniportal and Multiportal Video Assisted Thoracic Surgery for Stage II Post Pneumonic Bacterial Empyema Thoracis
Complicated Pneumonia (CP) in Children in South-East Europe
Uniportal VATS Versus Chest Tube for Early Empyema
VATS Decortication Versus IR Guided Chest Tube Insertion With Fibrinolytics for the Management of Empyema
The Role of Surgery in Patients With Coronavirus Disease - 19 (COVID-19) Related Thoracic Complications
Management of Pleural Space Infections
Treatment of Complicated Parapneumonic Effusion With Fibrinolytic Therapy Versus VATs Decortication
Retrospective Review on Patients With Culture Negative Empyema
Chest Wall Motion Analysis in Disease
Comparison of Intrapleural Urokinase and Video-Assisted Thorascopic Surgery in the Treatment of Parapneumonic Pleural Effusion in Children
Efficacy and Security of Intrapleurally Alteplase vs Urokinase for the Treatment of Complicated Parapneumonic Effusion and Empyema